{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:22:49Z","timestamp":1793161369299,"version":"4.5.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.beem.2024.101939","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T07:12:47Z","timestamp":1725693167000},"page":"101939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Recent progress in molecular classification of phaeochromocytoma and paraganglioma"],"prefix":"10.1016","volume":"38","author":[{"given":"Emma","family":"Boehm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"Clifton-Bligh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Tothill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2024.101939_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12105-017-0786-1","article-title":"Update from the 4th edition of the world health organization classification of head and neck tumours: paragangliomas","volume":"11","author":"Williams","year":"2017","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2024.101939_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41574-023-00926-0","article-title":"Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement","volume":"20","author":"Ta\u00efeb","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2024.101939_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S2213-8587(23)00038-4","article-title":"Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants","volume":"11","author":"Ta\u00efeb","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2024.101939_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib6","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2024.101939_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ERC-17-0306","article-title":"TERT structural rearrangements in metastatic pheochromocytomas","volume":"25","author":"Dwight","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib8","unstructured":"Flynn A. , Pattison A. , Balachander S. et al. Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles,. PREPRINT (Version 1) available at Research Square. 2024."},{"key":"10.1016\/j.beem.2024.101939_bib9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1677\/erc.1.00838","article-title":"Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome","volume":"11","author":"Eisenhofer","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","article-title":"A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas","volume":"1","author":"Dahia","year":"2005","journal-title":"PLoS Genet"},{"key":"10.1016\/j.beem.2024.101939_bib11","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","author":"Burnichon","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2024.101939_bib12","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1210\/jc.2015-3889","article-title":"Pheo-type: a diagnostic gene-expression assay for the classification of pheochromocytoma and paraganglioma","volume":"101","author":"Flynn","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2024.101939_bib14","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.2012.47.1912","article-title":"New syndrome of paraganglioma and somatostatinoma associated with polycythemia","volume":"31","author":"Pacak","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beem.2024.101939_bib15","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2024.101939_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Casc\u00f3n","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beem.2024.101939_bib17","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1158\/1078-0432.CCR-16-2250","article-title":"Targeted exome sequencing of Krebs cycle genes reveals candidate cancer-predisposing mutations in pheochromocytomas and paragangliomas","volume":"23","author":"Remacha","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2024.101939_bib18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajhg.2019.02.017","article-title":"Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas","volume":"104","author":"Remacha","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2024.101939_bib19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1210\/jc.2009-2170","article-title":"Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas","volume":"95","author":"Gaal","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib20","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1158\/0008-5472.CAN-17-2463","article-title":"Germline mutations in the mitochondrial 2-oxoglutarate\/malate carrier SLC25A11 gene confer a predisposition to metastatic paragangliomas","volume":"78","author":"Buffet","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2024.101939_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","author":"Yang","year":"2015","journal-title":"J Mol Med"},{"key":"10.1016\/j.beem.2024.101939_bib22","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","article-title":"Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas","volume":"22","author":"Toledo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2024.101939_bib23","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41436-018-0003-y","article-title":"Gain-of-function mutations in DNMT3A in patients with paraganglioma","volume":"20","author":"Remacha","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.beem.2024.101939_bib24","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1038\/s41467-022-34011-3","article-title":"Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment","volume":"13","author":"Zethoven","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2024.101939_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.965168","article-title":"Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas","volume":"12","author":"Brazda","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.beem.2024.101939_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41588-021-00806-1","article-title":"Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma","volume":"53","author":"Jansky","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2024.101939_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd3311","article-title":"Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell","volume":"7","author":"Kildisiute","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.beem.2024.101939_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3753","article-title":"Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla","volume":"357","author":"Furlan","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.beem.2024.101939_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnmol.2019.00006","article-title":"Schwann cell precursors generate the majority of chromaffin cells in Zuckerkandl organ and some sympathetic neurons in paraganglia","volume":"12","author":"Kastriti","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.beem.2024.101939_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007094","article-title":"The Warburg effect is genetically determined in inherited pheochromocytomas","volume":"4","author":"Favier","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.beem.2024.101939_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1593\/neo.122132","article-title":"Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas","volume":"15","author":"Shankavaram","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.beem.2024.101939_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1097-0215(19960220)69:1<17::AID-IJC4>3.0.CO;2-Z","article-title":"Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis","volume":"69","author":"Stumm","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib33","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0303","article-title":"EPAS1-related pheochromocytoma\/paraganglioma","volume":"31","author":"Alzahrani","year":"2024","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib34","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1101\/gad.12.21.3320","article-title":"The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development","volume":"12","author":"Tian","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.beem.2024.101939_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.yexcr.2004.10.003","article-title":"HIF-2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia","volume":"303","author":"Nilsson","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.beem.2024.101939_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1022192","article-title":"HIF and MYC signaling in adrenal neoplasms of the neural crest: implications for pediatrics","volume":"14","author":"Bechmann","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2024.101939_bib37","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","author":"Zhuang","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2024.101939_bib38","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJMc1716652","article-title":"EPAS1 mutations and paragangliomas in cyanotic congenital heart disease","volume":"378","author":"Vaidya","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2024.101939_bib39","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1210\/clinem\/dgad311","article-title":"Somatic EPAS1 variants in pheochromocytoma and paraganglioma in patients with sickle cell disease","volume":"108","author":"White","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib40","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1016\/j.celrep.2020.03.022","article-title":"TET-mediated hypermethylation primes SDH-deficient cells for HIF2\u03b1-driven mesenchymal transition","volume":"30","author":"Morin","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2024.101939_bib41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13148-023-01598-3","article-title":"A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide","volume":"15","author":"Chatzikyriakou","year":"2023","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.beem.2024.101939_bib42","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1158\/1078-0432.CCR-07-1867","article-title":"Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior","volume":"14","author":"Geli","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2024.101939_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/his.13402","article-title":"Pathology and genetics of phaeochromocytoma and paraganglioma","volume":"72","author":"Turchini","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.beem.2024.101939_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/ERC-21-0359","article-title":"Head\/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine","volume":"29","author":"Richter","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1186\/s12885-019-5813-z","article-title":"Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations","volume":"19","author":"Smestad","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1530\/EJE-13-0529","article-title":"Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites","volume":"169","author":"van Duinen","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2024.101939_bib47","series-title":"Arterial Chemoreceptors: Arterial Chemoreceptors","first-page":"137","article-title":"Neurotransmitters in Carotid Body Function: The Case of Dopamine \u2013 Invited Article","author":"Iturriaga","year":"2009"},{"key":"10.1016\/j.beem.2024.101939_bib48","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa502","article-title":"Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma","volume":"105","author":"Jiang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib49","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0230","article-title":"Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas","volume":"30","author":"Li","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib50","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1055\/s-0029-1224136","article-title":"RET expression and neuron-like differentiation of pheochromocytoma and normal chromaffin cells","volume":"41","author":"Powers","year":"2009","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.beem.2024.101939_bib51","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/PO.21.00127","article-title":"Novel RET fusion RET-SEPTIN9 predicts response to selective RET inhibition with selpercatinib in malignant pheochromocytoma","author":"Mweempwa","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.beem.2024.101939_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113070","article-title":"TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation","volume":"42","author":"Guo","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2024.101939_bib53","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89100","article-title":"Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics","volume":"12","author":"Walker","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.beem.2024.101939_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40246-017-0109-3","article-title":"The NF1 somatic mutational landscape in sporadic human cancers","volume":"11","author":"Philpott","year":"2017","journal-title":"Hum Genom"},{"key":"10.1016\/j.beem.2024.101939_bib55","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cancergen.2021.05.008","article-title":"Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHD","volume":"256-257","author":"Chatzikyriakou","year":"2021","journal-title":"Cancer Genet"},{"key":"10.1016\/j.beem.2024.101939_bib56","article-title":"Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma","volume":"13","author":"Mellid","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2024.101939_bib57","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/ijc.29957","article-title":"Malignant pheochromocytomas\/paragangliomas harbor mutations in transport and cell adhesion genes","volume":"138","author":"Wilz\u00e9n","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12022-022-09705-5","article-title":"Overview of the 2022 WHO classification of familial endocrine tumor syndromes","volume":"33","author":"Nos\u00e9","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib59","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/ijc.28868","article-title":"Opposing effects of HIF1\u03b1 and HIF2\u03b1 on chromaffin cell phenotypic features and tumor cell proliferation: insights from MYC-associated factor X","volume":"135","author":"Qin","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib60","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2024.101939_bib61","doi-asserted-by":"crossref","unstructured":"Mar\u00eda Monteagudo B.C. , \u00c1ngel M. Mart\u00ednez-Montes et al. MAML3-fusions modulate Vascular and Immune Tumor Microenvironment and Confer High Metastatic Risk in Pheochromocytoma and Paraganglioma. PREPRINT (Version 1) available at Research Square. 2023.","DOI":"10.21203\/rs.3.rs-3672711\/v1"},{"key":"10.1016\/j.beem.2024.101939_bib62","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgae233","article-title":"Outcomes of SDHB pathogenic variant carriers: a systematic review and meta-analysis","author":"Davidoff","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/PAS.0000000000001945","article-title":"A Clinicopathologic and molecular analysis of fumarate hydratase-deficient pheochromocytoma and paraganglioma","volume":"47","author":"Fuchs","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib64","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2017-00992","article-title":"Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years","volume":"102","author":"Hamidi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib65","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2589-7500(23)00094-8","article-title":"Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort","volume":"5","author":"Pamporaki","year":"2023","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.beem.2024.101939_bib66","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41467-023-36769-6","article-title":"Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma","volume":"14","author":"Calsina","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2024.101939_bib67","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12022-020-09633-2","article-title":"Immunohistochemical staining for SOX10 and SDHB in SDH-deficient paragangliomas indicates that sustentacular cells are not neoplastic","volume":"31","author":"Powers","year":"2020","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib68","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/path.4503","article-title":"The genomic landscape of phaeochromocytoma","volume":"236","author":"Flynn","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib69","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1158\/1078-0432.CCR-18-0139","article-title":"Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma","volume":"25","author":"Job","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2024.101939_bib70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2024.101939_bib71","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz168","article-title":"Transcriptome analysis of lncRNAs in pheochromocytomas and paragangliomas","volume":"105","author":"Job","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.587779","article-title":"Histopathological analysis of tumor microenvironment and angiogenesis in pheochromocytoma","volume":"11","author":"Gao","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2024.101939_bib73","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0002-9440(10)64400-8","article-title":"Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors","volume":"161","author":"Favier","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib74","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12022-011-9189-0","article-title":"Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma","volume":"23","author":"Favier","year":"2012","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216074","article-title":"Pericytes in the tumor microenvironment","volume":"556","author":"Jiang","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.beem.2024.101939_bib76","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ijc.32193","article-title":"In search of definitions: cancer-associated fibroblasts and their markers","volume":"146","author":"Nurmik","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib77","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2559.1986.tb02539.x","article-title":"Demonstration of S-100 protein in sustentacular cells of phaeochromocytomas and paragangliomas","volume":"10","author":"Schroder","year":"1986","journal-title":"Histopathology"},{"key":"10.1016\/j.beem.2024.101939_bib78","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/stem.2002","article-title":"Multipotent glia-like stem cells mediate stress adaptation","volume":"33","author":"Rubin de Celis","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.beem.2024.101939_bib79","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/EP:13:3:197","article-title":"Growth factors and cytokines in paragangliomas and pheochromocytomas, with special reference to sustentacular cells","volume":"13","author":"Kontogeorgos","year":"2002","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib80","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnae005","article-title":"The immune landscape of pheochromocytoma and paraganglioma: current advances and perspectives","author":"Uher","year":"2024","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2024.101939_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111193","article-title":"Succinate uptake by T cells suppresses their effector function via inhibition of mitochondrial glucose oxidation","volume":"40","author":"Gudgeon","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2024.101939_bib82","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-019-9575-6","article-title":"A previously unrecognized monocytic component of pheochromocytoma and paraganglioma","volume":"30","author":"Farhat","year":"2019","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib83","first-page":"589","article-title":"The immune cell infiltrate in the tumour microenvironment of phaeochromocytomas and paragangliomas","volume":"29","author":"Tufton","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2024.101939_bib85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12020-022-03218-1","article-title":"Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis","volume":"79","author":"Ghosal","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2024.101939_bib86","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.beem.2024.101939_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay6391","article-title":"Macrophages of diverse phenotypes drive vascularization of engineered tissues","volume":"6","author":"Graney","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.beem.2024.101939_bib88","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2024.101939_bib89","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41571-022-00722-1","article-title":"The emerging roles of \u03b3\u03b4 T cells in cancer immunotherapy","volume":"20","author":"Mensurado","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.beem.2024.101939_bib90","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/2326-6066.CIR-20-0817","article-title":"\u03b3\u03b4 T cells in Merkel cell carcinomas have a proinflammatory profile prognostic of patient survival","volume":"9","author":"Gherardin","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.beem.2024.101939_bib91","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1210\/jc.2019-00235","article-title":"Synonymous but not silent: a synonymous VHL variant in exon 2 confers susceptibility to familial pheochromocytoma and von Hippel-Lindau disease","volume":"104","author":"Flores","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/jmedgenet-2020-107656","article-title":"SDHB variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma","volume":"60","author":"Bayley","year":"2023","journal-title":"J Med Genet"},{"key":"10.1016\/j.beem.2024.101939_bib93","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/jc.2018-02411","article-title":"Positive impact of genetic test on the management and outcome of patients with paraganglioma and\/or pheochromocytoma","volume":"104","author":"Buffet","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib94","doi-asserted-by":"crossref","first-page":"e1907","DOI":"10.1210\/clinem\/dgac019","article-title":"Surveillance improves outcomes for carriers of SDHB pathogenic variants: a multicenter study","volume":"107","author":"Davidoff","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib95","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib96","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib97","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1530\/ERC-14-0016","article-title":"The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors","volume":"21","author":"Liu","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib98","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgae283","article-title":"Clinical activity of selpercatinib in RET-mutant pheochromocytoma","author":"Deschler-Baier","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib99","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa2110051","article-title":"Belzutifan, a potent HIF2\u03b1 inhibitor, in the Pacak-Zhuang syndrome","volume":"385","author":"Kamihara","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2024.101939_bib100","doi-asserted-by":"crossref","first-page":"L51","DOI":"10.1530\/ERC-17-0086","article-title":"SDHB mutation carriers with malignant pheochromocytoma respond better to CVD","volume":"24","author":"Fishbein","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib101","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/ijc.28913","article-title":"SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma","volume":"135","author":"Hadoux","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib102","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0140-6736(23)02554-0","article-title":"Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial","volume":"403","author":"Baudin","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2024.101939_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110216","article-title":"ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization","volume":"38","author":"Qin","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2024.101939_bib104","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1158\/0008-5472.CAN-18-3374","article-title":"Genome-wide CRISPR-Cas9 screen reveals selective vulnerability of ATRX-mutant cancers to WEE1 inhibition","volume":"80","author":"Liang","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2024.101939_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101147","article-title":"Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity","volume":"14","author":"Garbarino","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.beem.2024.101939_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102971","article-title":"Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma","volume":"59","author":"George","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.beem.2024.101939_bib107","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1038\/s41467-019-10179-z","article-title":"FANCM limits ALT activity by restricting telomeric replication stress induced by deregulated BLM and R-loops","volume":"10","author":"Silva","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2024.101939_bib108","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/cen.14106","article-title":"Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: a systematic review and meta-analysis","volume":"91","author":"Satapathy","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2024.101939_bib109","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/cen.12341","article-title":"131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis","volume":"80","author":"van Hulsteijn","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2024.101939_bib110","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2967\/jnumed.118.217463","article-title":"Efficacy and safety of high-specific-activity (131)I-MIBG therapy in patients with advanced pheochromocytoma or paraganglioma","volume":"60","author":"Pryma","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.beem.2024.101939_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030385","article-title":"HIF2alpha-associated pseudohypoxia promotes radioresistance in pheochromocytoma: insights from 3D models","volume":"13","author":"Seifert","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2024.101939_bib112","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00259-015-3179-2","article-title":"Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group","volume":"43","author":"Temple","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.beem.2024.101939_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30743","article-title":"Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to (131) I-MIBG in patients with relapsed\/refractory neuroblastoma","volume":"71","author":"Batra","year":"2024","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib114","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2967\/jnumed.115.154815","article-title":"Semiquantitative 123I-metaiodobenzylguanidine scintigraphy to distinguish pheochromocytoma and paraganglioma from physiologic adrenal uptake and its correlation with genotype-dependent expression of catecholamine transporters","volume":"56","author":"van Berkel","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.beem.2024.101939_bib115","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1210\/clinem\/dgad166","article-title":"Metastatic pheochromocytoma and paraganglioma: somatostatin receptor 2 expression, genetics, and therapeutic responses","volume":"108","author":"Fischer","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib116","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.humpath.2014.11.012","article-title":"Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas","volume":"46","author":"Elston","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.beem.2024.101939_bib117","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1210\/jc.2019-00018","article-title":"The role of 68Ga-DOTA-octreotate PET\/CT in follow-up of SDH-associated pheochromocytoma and paraganglioma","volume":"104","author":"Kong","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib118","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","article-title":"Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases","volume":"43","author":"Archier","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.beem.2024.101939_bib119","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1210\/jc.2017-02324","article-title":"18F-FDOPA PET\/CT imaging of MAX-Related pheochromocytoma","volume":"103","author":"Ta\u00efeb","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101939_bib120","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2967\/jnumed.116.187690","article-title":"Functional imaging signature of patients presenting with polycythemia\/paraganglioma syndromes","volume":"58","author":"Janssen","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.beem.2024.101939_bib121","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/JCB-199005","article-title":"Fluorescent mouse pheochromocytoma spheroids expressing hypoxia-inducible factor 2 alpha: morphologic and radiopharmacologic characterization","volume":"5","author":"Seifert","year":"2019","journal-title":"J Cell Biotechnol"},{"key":"10.1016\/j.beem.2024.101939_bib122","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-13-0384","article-title":"Frequent EPAS1\/HIF2\u03b1 exons 9 and 12 mutations in non-familial pheochromocytoma","volume":"21","author":"Welander","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101939_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26216567","article-title":"Deep membrane proteome profiling reveals overexpression of prostate-specific membrane antigen (PSMA) in high-risk human paraganglioma and pheochromocytoma, suggesting new theranostic opportunity","volume":"26","author":"Vit","year":"2021","journal-title":"Molecules"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T18:01:23Z","timestamp":1737309683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X24001155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":123,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1521690X24001155"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2024.101939","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent progress in molecular classification of phaeochromocytoma and paraganglioma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2024.101939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101939"}}